论文部分内容阅读
目的:观察小剂量保尔佳配合卡铂腹腔内注射治疗恶性腹水的疗效,以及对恶病质状态的改善情况。方法:治疗组及对照组均给卡铂200mg腹腔内注射,每2周一次,治疗组同时给保尔佳100mg,tid,po。结果:治疗组与对照组比较腹水完全缓解率、体力、食欲改善、腹痛减轻差异均有显著性。结论:小剂量保尔佳与卡铂腹腔内注射联合治疗恶性腹水,可提高疗效,增加机体抵抗力,改善病人生活质量
OBJECTIVE: To observe the efficacy of low-dose boljere combined with intraperitoneal injection of carboplatin in the treatment of malignant ascites, and to improve the status of cachexia. Methods: Both treatment group and control group received intraperitoneal injection of 200 mg carboplatin every 2 weeks. The treatment group also gave 100 mg, tid, po. Results: Compared with the control group, there were significant differences in the complete remission rate, physical strength, improvement of appetite, and reduction of abdominal pain in the treatment group and the control group. Conclusion: Intraperitoneal injection of low-dose boljere and carboplatin for the treatment of malignant ascites can improve the efficacy, increase the body resistance and improve the quality of life of patients.